{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
HOME
Create an Account
|
Support
|
Login
SEARCH
select
All
Colleagues
Content
Education
Groups
Quality Improvement Projects
Advanced
Username:
Password:
Forgot Password?
Create an Account
Remember Me
Forgot Password?
To change your password, please complete the fields below using the information entered during registration.
Username:
*
Change Your Password
Your password must be changed before you can log in. Please fill in the fields below.
Username:
New Password:
*
Confirm New
Password:
*
Account
Curriculum
Transcript
Preferences
Welcome & Mission Statement
FAQs
User Technical Support
Accreditation Legend
System Requirements
AAMC CME
ABMS
ACCME
AHRQ
AMA
CDC
MBC
TCOYD Making the Connection Between Patients and Providers with Type 1 and Type 2 Diabetes. (Santa Clara,CA- March 30, 2019)
Activity Details
Activity Name:
TCOYD Making the Connection Between Patients and Providers with Type 1 and Type 2 Diabetes. (Santa Clara,CA- March 30, 2019)
Course Objectives:
At course completion, participants should be able to:
Discuss the different pathophysiologic defects associated with type 2 diabetes and how pharmacologic agents address these specific abnormalities.
Summarize the recently published cardiovascular outcome trials (CVOTs) on oral and injectable type 2 medications and be able to discuss their implications in terms of clinical application.
Discuss approaches to combination therapy with the currently available oral agents including metformin, TZDs, an SFUs, SGLT-2 inhibitors, DPP4 inhibitors as well as GLP-1 receptor agonists.
Design rational and individualized treatment plans using mono- or combination therapy, including the optimal time for introducing each therapy.
Describe the advantages and limitations of modern insulin preparations and the various clinical strategies including combination therapy, split mixed, premixed, basal-bolus, and pump regimens.
Discuss patient-directed insulin titration strategies used in clinical practice for combination therapy and the basal bolus approach.
Review and describe the pathophysiology of type 2 diabetes as it relates to the role of newer medications such as incretin-based therapies and SGLT-2 inhibitors.
Outline the most up to date clinical information on GLP-1 receptor agonists and SGLT-2 inhibitors, including prescribing guidelines and safety issues.
Illustrate the physiologic secretion of insulin, glucagon, and amylin in the normal and diabetic state and propose a physiologic multiple daily injection regimen.
Identify appropriate candidates for pump therapy.
Location Information
Meeting Location:
Santa Clara Convention Center
Meeting Location URL:
https://tcoyd.org/mtc-san
ta-clara-2019/
Location Address:
5001 Great America Parkway
Location City:
Santa Clara
Location State:
CA
Location Postal Code:
95054
Location Country:
US
Activity Information
Start Date:
3/30/2019
End Date:
3/30/2019
Fees:
$50 - $65
Meeting URL:
https://tcoyd.org/mtc-san
ta-clara-2019/
Credit Information
Credit Amount:
6.25
Credit Unit:
Credits
Accreditation:
ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format:
Live Activity
Accreditor/Sponsor
Sponsor Name:
UC San Diego School of Medicine
Sponsor Address:
9500 Gilman Drive, MC0947
Sponsor City:
La Jolla
Sponsor State:
CA
Sponsor Postal Code:
92093
Sponsor Country:
US
Sponsor Phone:
+1-858-534-3940
Sponsor Email:
ocme@ucsd.edu
Contact Information
Contact Name:
Taking Control of Your Diabetes (TCOYD)
Contact Phone:
800-998-2693
Type:
Live Activity
1 Registered User
Live Meeting Information
Start:
Saturday, March 30, 2019
End:
Saturday, March 30, 2019
Location:
Santa Clara Convention Center
Santa Clara, CA 95054
US
Credits
6.25 Credits
>
Accreditation Council for Continuing Medical Education
>
AMA PRA Category 1 Credit
™
ACCME >
AMA PRA Category 1 Credit
™
Available:
6.25 Credits
Earned:
0 Credits
Expiration Date:
N/A
Terms of Service
Instructions go here
Loading...